IRIS
CONIGLIARO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.040
AS - Asia 4.275
EU - Europa 3.137
SA - Sud America 560
Continente sconosciuto - Info sul continente non disponibili 532
AF - Africa 96
OC - Oceania 89
Totale 32.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.783
SG - Singapore 1.859
CN - Cina 917
IT - Italia 716
RU - Federazione Russa 504
BR - Brasile 450
HK - Hong Kong 434
DE - Germania 317
VN - Vietnam 315
IE - Irlanda 286
FR - Francia 278
GB - Regno Unito 207
UA - Ucraina 204
FI - Finlandia 189
BD - Bangladesh 183
CA - Canada 134
JP - Giappone 118
SE - Svezia 100
NL - Olanda 76
KR - Corea 70
IN - India 67
ID - Indonesia 58
PL - Polonia 51
AU - Australia 46
NZ - Nuova Zelanda 43
DK - Danimarca 39
MX - Messico 39
TW - Taiwan 36
AR - Argentina 35
ES - Italia 34
TR - Turchia 30
ZA - Sudafrica 30
BE - Belgio 29
AT - Austria 27
EG - Egitto 23
SA - Arabia Saudita 23
EC - Ecuador 22
CO - Colombia 20
IR - Iran 19
UZ - Uzbekistan 17
JM - Giamaica 16
PK - Pakistan 16
IQ - Iraq 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
MA - Marocco 12
MY - Malesia 12
PH - Filippine 12
CR - Costa Rica 11
LV - Lettonia 11
CH - Svizzera 10
IL - Israele 10
NP - Nepal 10
RO - Romania 9
AZ - Azerbaigian 8
GT - Guatemala 8
NI - Nicaragua 8
VE - Venezuela 8
CL - Cile 7
SV - El Salvador 7
HN - Honduras 6
KE - Kenya 6
KZ - Kazakistan 6
UY - Uruguay 6
ET - Etiopia 5
HU - Ungheria 5
PE - Perù 5
PR - Porto Rico 5
SI - Slovenia 5
TH - Thailandia 5
TN - Tunisia 5
BG - Bulgaria 4
LB - Libano 4
OM - Oman 4
TT - Trinidad e Tobago 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
HR - Croazia 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
YE - Yemen 3
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
NO - Norvegia 2
SC - Seychelles 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AW - Aruba 1
Totale 32.175
Salva come PNG Salva come JPEG
Città #
Wilmington 5.509
Houston 4.807
Woodbridge 4.465
Ashburn 1.020
Singapore 986
Fairfield 634
San Jose 544
Ann Arbor 528
Chandler 426
Hong Kong 422
Dallas 415
Council Bluffs 283
Beijing 276
Seattle 270
New York 232
Dublin 231
Cambridge 212
Santa Clara 194
Medford 175
Los Angeles 174
Rome 171
Jacksonville 159
The Dalles 144
Helsinki 132
Ho Chi Minh City 115
Dearborn 88
Tokyo 88
Moscow 81
Lawrence 80
Denver 76
Lauterbourg 75
São Paulo 75
Buffalo 71
Zhengzhou 59
Hanoi 56
Chicago 53
Milan 53
North Bergen 51
Toronto 50
London 49
Redwood City 49
Tauranga 42
Phoenix 41
Munich 39
Orem 39
Brooklyn 36
Copenhagen 34
Jakarta 34
San Diego 34
Boardman 32
Seoul 32
Chengdu 31
Shenzhen 31
Amsterdam 30
Atlanta 30
Nuremberg 30
Nanjing 28
Guangzhou 27
Kraków 27
Menlo Park 27
Stockholm 25
Brussels 24
Frankfurt am Main 24
Johannesburg 23
Montreal 23
Redondo Beach 23
Shanghai 23
Taipei 22
Warsaw 22
Naples 21
Melbourne 20
Philadelphia 19
San Francisco 19
Chaozhou 18
Dong Ket 18
Suzhou 18
Boston 17
Chennai 17
Jeddah 17
Las Vegas 17
Norwalk 17
Mülheim 16
Mumbai 15
Augusta 14
Brasília 14
Palo Alto 14
Springfield 14
Haiphong 13
Mexico City 13
Bassano del Grappa 12
Columbus 12
Hefei 12
Lappeenranta 12
Leawood 12
Miami 12
Rio de Janeiro 12
Tanta 12
Kunming 11
Manchester 11
Mountain View 11
Totale 24.871
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 901
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 671
Complement, infection, and autoimmunity 618
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 544
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 534
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 533
Autoantibodies in inflammatory arthritis 526
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 521
The type I IFN system in rheumatoid arthritis 494
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 485
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 484
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 482
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 481
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 480
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 479
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 475
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 471
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 471
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 470
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 470
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 467
Identifying the cells breaching self-tolerance in autoimmunity. 457
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 454
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 449
Seronegative autoimmune diseases 446
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 442
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 440
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 438
Lymph node IL-18 expression in adult-onset Still's disease. 436
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 433
The interplay between inflammation and metabolism in rheumatoid arthritis 426
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 423
Insights on the role of physical activity in patients with rheumatoid arthritis 422
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 420
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 406
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 398
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 392
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 391
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 389
Histopathology of the skin in rheumatic diseases 374
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 372
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 365
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 353
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 350
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 348
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 343
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 330
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 324
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 319
Interaction between microbiome and host genetics in psoriatic arthritis 314
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 296
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 286
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 276
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 268
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 264
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 252
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 243
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 240
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 240
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 234
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 234
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 220
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 216
Severe lupus nephritis: an unexpected association with Fabry disease 205
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 194
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 194
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 192
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 188
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 182
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 181
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 181
COVID-19: disCOVering the role of complement system 176
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 171
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 171
Gender equality in Rheumatology 165
Tackling the autoimmune side in Spondyloarthritis: a systematic review 163
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 162
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 140
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 140
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 138
The effects of smoking, alcohol, and dietary habits on the progression and management of spondyloarthritis 136
The steroid-sparing effect of JAK inhibitors across multiple patient populations 136
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 134
Metabolic challenges of glucose and lipid dysregulation in psoriatic arthritis: a narrative review from pathogenesis to clinical practice 131
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 130
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 123
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 120
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 117
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 117
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 114
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 106
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 104
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 104
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 102
Kinesiophobia as part of the psychological burden in Spondyloarthritis: a case-control study 98
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 98
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 95
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 94
Sjögren’s disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment 93
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib 89
Totale 30.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 0 0 0 58 29 50 40 48 42 64 94 228
2022/20231.152 105 98 40 138 103 248 100 89 116 22 65 28
2023/2024570 60 17 22 15 67 127 15 77 26 19 42 83
2024/20252.800 87 541 356 153 34 254 120 112 224 244 360 315
2025/20266.287 368 393 821 642 535 234 757 609 575 591 437 325
2026/20272.774 401 539 1.082 752 0 0 0 0 0 0 0 0
Totale 32.729